JAK1 and rheumatoid arthritis: Tofacitinib (CP-690,550) is a JAK1/3 inhibitor with a lower affinity for JAK2 and is clinically used for the treatment of RA, psoriatic arthritis, and ulcerative colitis due to its immunosuppressive effects [16,188,189,190].